Company news

Royalty Pharma plc news in 2024

Royalty Pharma plc's news releases, calls and decks from 2024, newest first.

View company

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare

November 13, 2024

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million

November 6, 2024

Royalty Pharma Reports Third Quarter 2024 Results

November 5, 2024

Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™

November 3, 2024

Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo

November 3, 2024

Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024

October 15, 2024

Royalty Pharma Declares Fourth Quarter 2024 Dividend

October 10, 2024

Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement

September 2, 2024

Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference

August 27, 2024

Royalty Pharma Reports Second Quarter 2024 Results

August 7, 2024

Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital

July 23, 2024

Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024

July 18, 2024

Royalty Pharma Declares Third Quarter 2024 Dividend

July 16, 2024

Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

June 3, 2024

Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes

June 2, 2024

Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million

May 27, 2024

Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

May 21, 2024

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

May 8, 2024

Royalty Pharma Reports First Quarter 2024 Results

May 8, 2024

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024

April 18, 2024

Royalty Pharma Declares Second Quarter 2024 Dividend

April 16, 2024

Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference

February 27, 2024

Royalty Pharma Reports Q4 and Full Year 2023 Results

February 14, 2024

Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024

January 29, 2024

Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference

January 7, 2024

Calls in 2024

Decks in 2024